Trodelvy

News

Radiology technician examens mammography test on location

NICE backs two new breast cancer drugs for NHS use

Cost-effectiveness watchdog NICE has recommended routine NHS use of two new therapies for women with advanced breast cancer – Gilead's Trodelvy and Novartis' Piqray – in England.

News

ASCO22: Gilead makes case for Trodelvy in advanced breast ca...

In March, Gilead Sciences reported positive results for its TROPiCS-02 study of Trodelvy, but the guarded tone of the announcement led to speculation that the data was not as strong as hope

News

NICE verdict on Trodelvy threatens unequal access to drug in...

In draft guidance, NICE has said it cannot recommend Gilead Sciences' Trodelvy in triple-negative breast cancer (TNBC), setting up a disparity in access to the drug via the NHS in the UK.

News

The data are in – so will Gilead's Trodelvy achieve its pote...

The results of Gilead's much-anticipated TROPiCS-02 study of Trodelvy are in, and while the company says top-line data are positive, its guarded stance has rung some alarm bells.

News

AZ, Daiichi take aim at Gilead in triple-negative breast can...

AstraZeneca and Daiichi Sankyo have reported new data with their antibody-drug conjugate for triple-negative breast cancer (TNBC), as they build a case to challenge Gilead's already-markete

News

Gilead moves closer to Chinese filing for Trodelvy in TNBC

Gilead Sciences' Trodelvy has met its objectives in a phase 2b trial in triple-negative breast cancer (TNBC) carried out in China by its partner Everest Medicines, moving it closer to a reg

NICE backs two new breast cancer drugs for NHS use

ASCO22: Gilead makes case for Trodelvy in advanced breast ca...

NICE verdict on Trodelvy threatens unequal access to drug in...

The data are in – so will Gilead's Trodelvy achieve its pote...

AZ, Daiichi take aim at Gilead in triple-negative breast can...

Gilead moves closer to Chinese filing for Trodelvy in TNBC

On genomics, NGS, and doing much more good than bad, with Ma...

How to meet your physicians where they are online

Trodelvy

Editor's Picks